Mesothelioma Asbestos Lawyer Videos Added to Lawyer Central’s … – Earthtimes
Filed in Mesothelioma News on Nov.19, 2009
STOCKHOLM – Regulatory News: Medivir (STO:MVIRB): The Epiphany Biosciences press release reads as follows; Epiphany Biosciences announced results from its Phase 2b dose-ranging study of EPB-348 (valomaciclovir) in patients with shi Share your next …
Read the whole story here:
Mesothelioma Asbestos Lawyer Videos Added to Lawyer Central’s … – Earthtimes
Tags: announced-results, epb, from-its, medivir, mvirb, phase, press-release, reads-as-follows, regulatory, sto

Leave a Reply
You must be logged in to post a comment.